Drug
Imm 101
Imm 101: highest development phase Phase 3, developed by Applied Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Applied Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMM-101 NCT04442048 | Phase 3 | Cancer |
Latest
No recent events.
Follow Imm 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.